

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 9.63419522 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 9.63419522 |
| 3 | interferon-gamma production (GO:0032609) | 7.76267728 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.98050338 |
| 5 | cellular response to interleukin-15 (GO:0071350) | 6.67375531 |
| 6 | response to interleukin-15 (GO:0070672) | 6.26278444 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.68570739 |
| 8 | negative thymic T cell selection (GO:0045060) | 5.66157040 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.60434579 |
| 10 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.51157494 |
| 11 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.51157494 |
| 12 | negative T cell selection (GO:0043383) | 5.45473221 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.36759198 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.08466189 |
| 15 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 5.08027823 |
| 16 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.71372295 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.62316889 |
| 18 | negative regulation of leukocyte mediated immunity (GO:0002704) | 4.53606719 |
| 19 | leukocyte aggregation (GO:0070486) | 4.50514882 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.49385075 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.45113950 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.44674696 |
| 23 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.39492073 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 4.21933636 |
| 25 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.19007934 |
| 26 | cellular defense response (GO:0006968) | 4.15821872 |
| 27 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.11657204 |
| 28 | cellular extravasation (GO:0045123) | 4.07516913 |
| 29 | negative regulation of type 2 immune response (GO:0002829) | 4.05743935 |
| 30 | regulation of cell killing (GO:0031341) | 3.93537417 |
| 31 | T cell selection (GO:0045058) | 3.90633668 |
| 32 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.86674531 |
| 33 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.86201130 |
| 34 | positive thymic T cell selection (GO:0045059) | 3.85020500 |
| 35 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.80428541 |
| 36 | positive regulation of mast cell activation (GO:0033005) | 3.79316007 |
| 37 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.75349305 |
| 38 | T cell migration (GO:0072678) | 3.74798288 |
| 39 | thymic T cell selection (GO:0045061) | 3.74259181 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.73188778 |
| 41 | activated T cell proliferation (GO:0050798) | 3.72134509 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 3.70603831 |
| 43 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.68433217 |
| 44 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.68433217 |
| 45 | modulation by symbiont of host immune response (GO:0052553) | 3.68433217 |
| 46 | positive regulation by symbiont of host defense response (GO:0052509) | 3.68433217 |
| 47 | modulation by symbiont of host defense response (GO:0052031) | 3.68433217 |
| 48 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.68433217 |
| 49 | B cell receptor signaling pathway (GO:0050853) | 3.66104753 |
| 50 | positive regulation of cell killing (GO:0031343) | 3.65648062 |
| 51 | negative regulation of innate immune response (GO:0045824) | 3.64583298 |
| 52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.64299620 |
| 53 | regulation of mast cell degranulation (GO:0043304) | 3.58107712 |
| 54 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.53343640 |
| 55 | response to muramyl dipeptide (GO:0032495) | 3.50105583 |
| 56 | cellular response to type I interferon (GO:0071357) | 3.48315651 |
| 57 | type I interferon signaling pathway (GO:0060337) | 3.48315651 |
| 58 | neutrophil activation (GO:0042119) | 3.45617637 |
| 59 | mast cell activation (GO:0045576) | 3.45056361 |
| 60 | regulation of mast cell activation (GO:0033003) | 3.44510551 |
| 61 | response to type I interferon (GO:0034340) | 3.44264507 |
| 62 | positive T cell selection (GO:0043368) | 3.38709166 |
| 63 | rRNA catabolic process (GO:0016075) | 3.37264482 |
| 64 | B cell mediated immunity (GO:0019724) | 3.36735901 |
| 65 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.34494519 |
| 66 | positive regulation of mast cell degranulation (GO:0043306) | 3.33056465 |
| 67 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.33056465 |
| 68 | dendritic cell chemotaxis (GO:0002407) | 3.32662905 |
| 69 | negative regulation of phagocytosis (GO:0050765) | 3.31889661 |
| 70 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.31741589 |
| 71 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.31138853 |
| 72 | natural killer cell activation (GO:0030101) | 3.30956880 |
| 73 | natural killer cell differentiation (GO:0001779) | 3.28596296 |
| 74 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.25728743 |
| 75 | positive regulation of B cell differentiation (GO:0045579) | 3.25561006 |
| 76 | regulation of leukocyte mediated immunity (GO:0002703) | 3.20394279 |
| 77 | detection of other organism (GO:0098543) | 3.18954926 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 3.17974604 |
| 79 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.14520908 |
| 80 | positive regulation of T cell cytokine production (GO:0002726) | 3.13354168 |
| 81 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.11829327 |
| 82 | detection of bacterium (GO:0016045) | 3.11685124 |
| 83 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.11413345 |
| 84 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.11411441 |
| 85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.08700430 |
| 86 | negative regulation of bone resorption (GO:0045779) | 3.06762590 |
| 87 | granulocyte activation (GO:0036230) | 3.05332843 |
| 88 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.03407241 |
| 89 | microglial cell activation (GO:0001774) | 3.03332421 |
| 90 | dendritic cell migration (GO:0036336) | 3.01672259 |
| 91 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.00319169 |
| 92 | regulation of T cell mediated immunity (GO:0002709) | 3.00228539 |
| 93 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.00220898 |
| 94 | positive regulation of T cell mediated immunity (GO:0002711) | 2.99469200 |
| 95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.98573368 |
| 96 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.92958444 |
| 97 | regulation of regulatory T cell differentiation (GO:0045589) | 2.92896248 |
| 98 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.92462688 |
| 99 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.91406615 |
| 100 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.91406615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.59155998 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.34004771 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.84904266 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.94645075 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.87240438 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.84099339 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.60990810 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.58082822 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 3.17228618 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.13184204 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.12097631 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.87353312 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.82574769 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.67205817 |
| 15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.67203922 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57068527 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46516275 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.43102781 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.40392457 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.36091239 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.31349331 |
| 22 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.29100498 |
| 23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25813127 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.25319630 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.24140696 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21609541 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.19438331 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.19164278 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.18228862 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.16967437 |
| 31 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.15597589 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.15294028 |
| 33 | GATA3_26560356_Chip-Seq_TH2_Human | 2.09838706 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.88301232 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.84794248 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.80855021 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79735859 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.77271161 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.72935955 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67001483 |
| 41 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63756934 |
| 42 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.58452686 |
| 43 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52110182 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46171212 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.46156972 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44649221 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43945419 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42250475 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41602424 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.41468999 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38161780 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36234351 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26575839 |
| 54 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26300796 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26171762 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25300908 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24652148 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24052936 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22802503 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.22660136 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19943472 |
| 62 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.19430004 |
| 63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18217642 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17296702 |
| 65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16287945 |
| 66 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15759713 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14918571 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12673562 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11855707 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10125498 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07238080 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06311047 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06129013 |
| 74 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05759244 |
| 75 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01442480 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96855606 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96612402 |
| 78 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95430402 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95328521 |
| 80 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93608312 |
| 81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.91974028 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91702647 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89524377 |
| 84 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88214474 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88032739 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87794783 |
| 87 | GATA3_26560356_Chip-Seq_TH1_Human | 0.87736041 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87011827 |
| 89 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85686597 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82759366 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81152628 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80946844 |
| 93 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80929222 |
| 94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.79298275 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77310273 |
| 96 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75369093 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.74743701 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74690408 |
| 99 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73804531 |
| 100 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.73641954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.82919415 |
| 2 | MP0003724_increased_susceptibility_to | 4.46079015 |
| 3 | MP0003436_decreased_susceptibility_to | 4.10430534 |
| 4 | MP0001835_abnormal_antigen_presentation | 4.04844079 |
| 5 | MP0006082_CNS_inflammation | 4.01522571 |
| 6 | MP0000685_abnormal_immune_system | 3.57395936 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.35395394 |
| 8 | MP0003763_abnormal_thymus_physiology | 3.29432457 |
| 9 | MP0001800_abnormal_humoral_immune | 3.26742833 |
| 10 | MP0005025_abnormal_response_to | 3.04603014 |
| 11 | MP0009785_altered_susceptibility_to | 2.96689130 |
| 12 | MP0001790_abnormal_immune_system | 2.87217506 |
| 13 | MP0005387_immune_system_phenotype | 2.87217506 |
| 14 | MP0002419_abnormal_innate_immunity | 2.85751251 |
| 15 | MP0002723_abnormal_immune_serum | 2.83708010 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.75576334 |
| 17 | MP0001819_abnormal_immune_cell | 2.73277219 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.60475830 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.30874009 |
| 20 | MP0002405_respiratory_system_inflammati | 2.26019531 |
| 21 | MP0002398_abnormal_bone_marrow | 2.19300653 |
| 22 | MP0004947_skin_inflammation | 2.17398417 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.13457173 |
| 24 | MP0000716_abnormal_immune_system | 2.05799576 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.05022349 |
| 26 | MP0000703_abnormal_thymus_morphology | 2.02288067 |
| 27 | MP0001986_abnormal_taste_sensitivity | 2.01004850 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 2.00044774 |
| 29 | MP0002722_abnormal_immune_system | 1.88369923 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.85351680 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.82945702 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.80829124 |
| 33 | MP0002132_abnormal_respiratory_system | 1.73377069 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.63319340 |
| 35 | MP0005310_abnormal_salivary_gland | 1.62270042 |
| 36 | MP0002429_abnormal_blood_cell | 1.59770802 |
| 37 | MP0003303_peritoneal_inflammation | 1.58699443 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.58501674 |
| 39 | MP0000858_altered_metastatic_potential | 1.45323209 |
| 40 | MP0009764_decreased_sensitivity_to | 1.42990841 |
| 41 | MP0004381_abnormal_hair_follicle | 1.41392280 |
| 42 | MP0001851_eye_inflammation | 1.40075894 |
| 43 | MP0003866_abnormal_defecation | 1.38936809 |
| 44 | MP0008469_abnormal_protein_level | 1.38852255 |
| 45 | MP0001348_abnormal_lacrimal_gland | 1.37618699 |
| 46 | MP0004130_abnormal_muscle_cell | 1.31458277 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.31178749 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.28086910 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.28060765 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.25677282 |
| 51 | MP0003448_altered_tumor_morphology | 1.20468047 |
| 52 | MP0001873_stomach_inflammation | 1.18913505 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.18414963 |
| 54 | MP0004043_abnormal_pH_regulation | 1.18249112 |
| 55 | MP0003828_pulmonary_edema | 1.10960909 |
| 56 | MP0003690_abnormal_glial_cell | 1.07836768 |
| 57 | MP0006054_spinal_hemorrhage | 1.07346743 |
| 58 | MP0004883_abnormal_blood_vessel | 1.06817476 |
| 59 | MP0002006_tumorigenesis | 1.05100746 |
| 60 | MP0002163_abnormal_gland_morphology | 1.02314531 |
| 61 | MP0002009_preneoplasia | 1.01480018 |
| 62 | MP0002933_joint_inflammation | 1.00589663 |
| 63 | MP0009763_increased_sensitivity_to | 0.95492499 |
| 64 | MP0010307_abnormal_tumor_latency | 0.93100681 |
| 65 | MP0002998_abnormal_bone_remodeling | 0.89761469 |
| 66 | MP0009278_abnormal_bone_marrow | 0.84533062 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 0.83618653 |
| 68 | MP0002876_abnormal_thyroid_physiology | 0.81992561 |
| 69 | MP0002019_abnormal_tumor_incidence | 0.80733026 |
| 70 | MP0005390_skeleton_phenotype | 0.79943315 |
| 71 | MP0000490_abnormal_crypts_of | 0.76518750 |
| 72 | MP0005164_abnormal_response_to | 0.76271920 |
| 73 | MP0004510_myositis | 0.75096139 |
| 74 | MP0008873_increased_physiological_sensi | 0.73140210 |
| 75 | MP0002693_abnormal_pancreas_physiology | 0.73017737 |
| 76 | MP0005166_decreased_susceptibility_to | 0.71351653 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.70848066 |
| 78 | MP0001853_heart_inflammation | 0.70287881 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.69132265 |
| 80 | MP0000249_abnormal_blood_vessel | 0.68495414 |
| 81 | MP0003045_fibrosis | 0.64998625 |
| 82 | MP0003252_abnormal_bile_duct | 0.61677336 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.60293333 |
| 84 | MP0008260_abnormal_autophagy | 0.56515945 |
| 85 | MP0000569_abnormal_digit_pigmentation | 0.54932029 |
| 86 | MP0003638_abnormal_response/metabolism_ | 0.54281557 |
| 87 | MP0002332_abnormal_exercise_endurance | 0.53730394 |
| 88 | MP0000920_abnormal_myelination | 0.53219855 |
| 89 | MP0003075_altered_response_to | 0.51645196 |
| 90 | MP0004142_abnormal_muscle_tone | 0.51512457 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.51410934 |
| 92 | MP0001545_abnormal_hematopoietic_system | 0.51222736 |
| 93 | MP0005397_hematopoietic_system_phenotyp | 0.51222736 |
| 94 | MP0004484_altered_response_of | 0.50502082 |
| 95 | MP0000343_altered_response_to | 0.49394314 |
| 96 | MP0001663_abnormal_digestive_system | 0.48796708 |
| 97 | MP0001346_abnormal_lacrimal_gland | 0.47682559 |
| 98 | MP0001919_abnormal_reproductive_system | 0.45546633 |
| 99 | MP0008874_decreased_physiological_sensi | 0.44281909 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.43710270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 6.29268911 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 6.09590270 |
| 3 | Optic neuritis (HP:0100653) | 6.09590270 |
| 4 | Orchitis (HP:0100796) | 5.88304159 |
| 5 | Encephalitis (HP:0002383) | 5.72438772 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.49227202 |
| 7 | Eczematoid dermatitis (HP:0000976) | 5.03389048 |
| 8 | Abnormality of T cell number (HP:0011839) | 4.90427993 |
| 9 | Increased IgM level (HP:0003496) | 4.82889552 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.73202123 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.64597395 |
| 12 | T lymphocytopenia (HP:0005403) | 4.50851247 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.45117735 |
| 14 | Stomatitis (HP:0010280) | 4.42584589 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.34521987 |
| 16 | Meningitis (HP:0001287) | 4.26261579 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.23880383 |
| 18 | IgG deficiency (HP:0004315) | 4.21134332 |
| 19 | Keratoconjunctivitis sicca (HP:0001097) | 4.20630172 |
| 20 | Keratoconjunctivitis (HP:0001096) | 4.16116278 |
| 21 | Abnormality of T cells (HP:0002843) | 4.07683564 |
| 22 | Eosinophilia (HP:0001880) | 3.97089752 |
| 23 | Pustule (HP:0200039) | 3.80191991 |
| 24 | Granulocytopenia (HP:0001913) | 3.75050708 |
| 25 | Hypoproteinemia (HP:0003075) | 3.74578154 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 3.71184916 |
| 27 | Joint swelling (HP:0001386) | 3.69756745 |
| 28 | Hemoptysis (HP:0002105) | 3.64844560 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 3.61071969 |
| 30 | Hemiplegia (HP:0002301) | 3.58610019 |
| 31 | Abnormality of eosinophils (HP:0001879) | 3.49365064 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 3.48555044 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.48555044 |
| 34 | Prolonged bleeding time (HP:0003010) | 3.38557029 |
| 35 | Leukocytosis (HP:0001974) | 3.38469403 |
| 36 | Vasculitis (HP:0002633) | 3.37035004 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 3.35375615 |
| 38 | Recurrent skin infections (HP:0001581) | 3.34650046 |
| 39 | Pulmonary infiltrates (HP:0002113) | 3.25786345 |
| 40 | Arterial thrombosis (HP:0004420) | 3.24408651 |
| 41 | Anorexia (HP:0002039) | 3.11321134 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.00958179 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.98098397 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 2.93030068 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.91602788 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89080510 |
| 47 | Obstructive lung disease (HP:0006536) | 2.89080510 |
| 48 | Chest pain (HP:0100749) | 2.85725792 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.82650673 |
| 50 | Increased serum ferritin (HP:0003281) | 2.78556283 |
| 51 | Severe combined immunodeficiency (HP:0004430) | 2.77073021 |
| 52 | Autoimmune hemolytic anemia (HP:0001890) | 2.76897568 |
| 53 | Gingival bleeding (HP:0000225) | 2.69467637 |
| 54 | Pulmonary embolism (HP:0002204) | 2.69460729 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.64598573 |
| 56 | Gangrene (HP:0100758) | 2.62102879 |
| 57 | Hypochromic anemia (HP:0001931) | 2.61412968 |
| 58 | Epistaxis (HP:0000421) | 2.60227051 |
| 59 | Keratitis (HP:0000491) | 2.56496662 |
| 60 | Cheilitis (HP:0100825) | 2.50132675 |
| 61 | Abnormality of iron homeostasis (HP:0011031) | 2.45461235 |
| 62 | Abnormality of the endocardium (HP:0004306) | 2.45223718 |
| 63 | Glomerulopathy (HP:0100820) | 2.44346352 |
| 64 | Subacute progressive viral hepatitis (HP:0006572) | 2.37988159 |
| 65 | Urticaria (HP:0001025) | 2.36407266 |
| 66 | Recurrent viral infections (HP:0004429) | 2.34888199 |
| 67 | Hypergammaglobulinemia (HP:0010702) | 2.32816055 |
| 68 | Abnormality of the pleura (HP:0002103) | 2.31339338 |
| 69 | Colitis (HP:0002583) | 2.27672151 |
| 70 | Stomach cancer (HP:0012126) | 2.27409403 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.25454636 |
| 72 | Viral hepatitis (HP:0006562) | 2.23715343 |
| 73 | Vertigo (HP:0002321) | 2.21924189 |
| 74 | Recurrent bronchitis (HP:0002837) | 2.21034251 |
| 75 | Increased CSF protein (HP:0002922) | 2.20346380 |
| 76 | Increased IgE level (HP:0003212) | 2.18587474 |
| 77 | Verrucae (HP:0200043) | 2.18333915 |
| 78 | Papilloma (HP:0012740) | 2.18333915 |
| 79 | Spondylolisthesis (HP:0003302) | 2.17454117 |
| 80 | Abnormality of the common coagulation pathway (HP:0010990) | 2.14009060 |
| 81 | Gingivitis (HP:0000230) | 2.12335303 |
| 82 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.12079958 |
| 83 | Combined immunodeficiency (HP:0005387) | 2.10944631 |
| 84 | Chronic diarrhea (HP:0002028) | 2.09794825 |
| 85 | Fatigue (HP:0012378) | 2.08013006 |
| 86 | Facial diplegia (HP:0001349) | 2.00818560 |
| 87 | Acne (HP:0001061) | 1.99023203 |
| 88 | Abnormality of intracranial pressure (HP:0012640) | 1.96370408 |
| 89 | Increased intracranial pressure (HP:0002516) | 1.96370408 |
| 90 | Alveolar cell carcinoma (HP:0006519) | 1.94425080 |
| 91 | Conical tooth (HP:0000698) | 1.88841106 |
| 92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.88034886 |
| 93 | Abnormal albumin level (HP:0012116) | 1.82833268 |
| 94 | Hypoalbuminemia (HP:0003073) | 1.82833268 |
| 95 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.80823969 |
| 96 | Lymphoma (HP:0002665) | 1.79754652 |
| 97 | Tetraplegia (HP:0002445) | 1.77942313 |
| 98 | Hematochezia (HP:0002573) | 1.74045365 |
| 99 | Arthralgia (HP:0002829) | 1.73978372 |
| 100 | Thrombophlebitis (HP:0004418) | 1.73923140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.34571931 |
| 2 | SIK2 | 4.07854497 |
| 3 | GRK6 | 3.82408035 |
| 4 | MAP4K1 | 3.32635683 |
| 5 | MAP3K14 | 2.89706136 |
| 6 | JAK3 | 2.64270808 |
| 7 | RIPK4 | 2.52314057 |
| 8 | FES | 2.49338585 |
| 9 | BTK | 1.99950113 |
| 10 | ZAP70 | 1.98387048 |
| 11 | CSK | 1.90972099 |
| 12 | TBK1 | 1.90896471 |
| 13 | BLK | 1.77133292 |
| 14 | IKBKE | 1.76323403 |
| 15 | JAK1 | 1.74661965 |
| 16 | TYK2 | 1.74107816 |
| 17 | ITK | 1.73077546 |
| 18 | STK10 | 1.67025180 |
| 19 | ACVR1B | 1.60873157 |
| 20 | MAP3K13 | 1.57520587 |
| 21 | TNK2 | 1.54466250 |
| 22 | IKBKB | 1.54263165 |
| 23 | TAOK3 | 1.50799049 |
| 24 | TEC | 1.49759062 |
| 25 | SYK | 1.48140636 |
| 26 | PRPF4B | 1.48065112 |
| 27 | LCK | 1.47933024 |
| 28 | IRAK4 | 1.39738100 |
| 29 | GRK7 | 1.39213032 |
| 30 | MAP2K6 | 1.37199574 |
| 31 | HCK | 1.35501160 |
| 32 | MAP2K3 | 1.34513081 |
| 33 | LYN | 1.31789793 |
| 34 | TGFBR2 | 1.29566241 |
| 35 | NEK2 | 1.29186677 |
| 36 | CDK3 | 1.27438813 |
| 37 | PIK3CG | 1.26200285 |
| 38 | KIT | 1.22237060 |
| 39 | MAP2K2 | 1.19189090 |
| 40 | CSF1R | 1.16914447 |
| 41 | SIK3 | 1.12994405 |
| 42 | NUAK1 | 1.07216832 |
| 43 | CAMKK2 | 1.06384591 |
| 44 | EPHB1 | 1.02555320 |
| 45 | FGR | 0.99181533 |
| 46 | BRD4 | 0.93970732 |
| 47 | JAK2 | 0.86776602 |
| 48 | PIM1 | 0.83289619 |
| 49 | MOS | 0.80790076 |
| 50 | MAP3K3 | 0.80311200 |
| 51 | TLK1 | 0.77475491 |
| 52 | MARK3 | 0.77318536 |
| 53 | ERN1 | 0.77018228 |
| 54 | RAF1 | 0.74180516 |
| 55 | PRKCQ | 0.73909142 |
| 56 | BMPR2 | 0.71855940 |
| 57 | BCR | 0.69381431 |
| 58 | KSR2 | 0.67809504 |
| 59 | MAPK7 | 0.67180404 |
| 60 | MAP3K2 | 0.65325025 |
| 61 | PDK1 | 0.65284605 |
| 62 | CDK4 | 0.60217497 |
| 63 | FYN | 0.59638996 |
| 64 | GRK5 | 0.57318754 |
| 65 | CAMKK1 | 0.55975905 |
| 66 | KDR | 0.53853471 |
| 67 | EIF2AK2 | 0.52923821 |
| 68 | PRKCH | 0.51153433 |
| 69 | CHUK | 0.49939275 |
| 70 | TESK2 | 0.47888637 |
| 71 | MAPK11 | 0.46204642 |
| 72 | IGF1R | 0.41121222 |
| 73 | STK24 | 0.40985594 |
| 74 | PTK2B | 0.40874097 |
| 75 | MAP3K7 | 0.39176062 |
| 76 | MAPK12 | 0.38816668 |
| 77 | KSR1 | 0.37766461 |
| 78 | MATK | 0.36892961 |
| 79 | MAP3K1 | 0.33748702 |
| 80 | ABL1 | 0.33741576 |
| 81 | PRKCD | 0.32545603 |
| 82 | STK38 | 0.32417771 |
| 83 | MAP3K11 | 0.31547007 |
| 84 | PTK6 | 0.31410876 |
| 85 | ADRBK2 | 0.30524771 |
| 86 | INSR | 0.30469101 |
| 87 | YES1 | 0.30015137 |
| 88 | MAPKAPK2 | 0.27999748 |
| 89 | MAPK13 | 0.27781191 |
| 90 | FGFR4 | 0.26705188 |
| 91 | RPS6KA6 | 0.26422400 |
| 92 | FGFR3 | 0.25554073 |
| 93 | SGK3 | 0.24621778 |
| 94 | MARK2 | 0.24520614 |
| 95 | TAOK1 | 0.22407394 |
| 96 | EGFR | 0.22371733 |
| 97 | STK11 | 0.20005635 |
| 98 | RPS6KL1 | 0.18561238 |
| 99 | RPS6KC1 | 0.18561238 |
| 100 | IRAK1 | 0.18267505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.06210355 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.17607497 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.37565929 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.27445797 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.18597419 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.72102255 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.62875885 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.61807487 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.34164159 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.26032406 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.13488275 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.06389873 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.05814090 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.00669272 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.94168271 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.79399402 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60678964 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60478199 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58064828 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.57164011 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.56980233 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.56908267 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.55692596 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50250921 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.49258975 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48139206 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46104407 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41917319 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37060470 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.36854921 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36033890 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.26287430 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.24003966 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.23076669 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19368332 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17921975 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.10497630 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.06906221 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.04079121 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02020128 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.00201072 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96209228 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90757624 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86471769 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 0.84433522 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83032975 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 0.79456628 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79237634 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78014684 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 0.77318884 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75733285 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66105826 |
| 53 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65982137 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65835765 |
| 55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65399524 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63669206 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58819830 |
| 58 | Endocytosis_Homo sapiens_hsa04144 | 0.55342905 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54924243 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54310657 |
| 61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53803788 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52181708 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50823916 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49817641 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47926561 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47868531 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47412945 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45494824 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44655064 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44337994 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44082184 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43807058 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43689637 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43199508 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.42955206 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42546175 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.38685945 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37904078 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34780230 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34504417 |
| 81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34370543 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34162801 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.33454647 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.32162329 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31475516 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.28768642 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26486970 |
| 88 | Colorectal cancer_Homo sapiens_hsa05210 | 0.23354255 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23101127 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.22264261 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.22086285 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.21517933 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.20931393 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.20783517 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20410584 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.20289175 |
| 97 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.19373357 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18493768 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.18321146 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.17749433 |

